destiny-breast03: safety follow-up results
Published 2 years ago • 192 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
4:07
safety follow-up of the randomized, phase 3 study destiny-breast03
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
2:27
destiny-breast03: practice-changing results from esmo 2021
-
0:48
highlights from esmo: destiny-breast03
-
12:19
sabcs 2022: updated survival results of the randomized, phase 3 study destiny-breast03 q & a
-
2:16
sabcs 2022: destiny-breast02 destiny-breast03
-
2:48
destiny-breast03: t-dxd is superior to t-dm1 in her2 metastatic breast cancer
-
1:11
32 month follow-up of mountaineer: tucatinib and trastuzumab in her2 mcrc
-
4:56
her2 mbc: study design and results of destiny-breast01
-
3:46
aphinity: 6-year follow-up results of dual her2 blockade in her2 breast cancer
-
3:06
trastuzumab deruxtecan effective against brain metastases in her2-positive breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
7:12
t-dxd demonstrates high levels of efficacy in patients with her2 unresectable and/or mbc previo...
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients